Month: May 2021

Results for the First Quarter of 2021Net income of $10.7 million, or $0.45 per common unit Adjusted EBITDA of $13.8 million and distributable cash flow of $11.7 million Quarterly cash distribution of $0.12 per unit Distribution coverage ratio of 4.13x, LTM distribution coverage ratio of 4.02xOMAHA, Neb., May 03, 2021 (GLOBE NEWSWIRE) — Green Plains Partners LP (NASDAQ:GPP) today announced financial and operating results for the first quarter of 2021. Net income attributable to the partnership was $10.7 million, or $0.45 per common unit, for the first quarter of 2021 compared with net income of $10.4 million, or $0.44 per common unit, for the same period in 2020. The partnership also reported adjusted EBITDA of $13.8 million and distributable cash flow of $11.7 million for the first quarter of 2021, compared with adjusted EBITDA...

Piraeus, Greece, May 03, 2021 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog”) (NYSE: GLOG) today announced that it has called a special general meeting of shareholders (the “Special Meeting”), to be held on June 4, 2021, to consider and vote on the proposal to approve (i) the previously announced merger contemplated by that certain agreement and plan of merger, dated as of February 21, 2021 (as amended, the “Merger Agreement”), by and among GasLog, GEPIF III Crown Bidco L.P., a Cayman Islands exempted company, and GEPIF III Crown MergerCo Limited, a Bermuda exempted company (“Merger Sub”), pursuant to which Merger Sub will merge with and into GasLog with GasLog as the surviving company in the merger, (ii) the Merger Agreement and (iii) the statutory merger agreement contemplated by the Merger Agreement. Holders of record of GasLog’s...

JOHNS CREEK, Ga., May 03, 2021 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, today announced the appointment of Ms. Priyanka Kaul as a new independent director to the Ebix Board. In a career spanning 22 years, Priyanka has held various leadership positions including being the CEO of Forbes India and Division President of Network 18 Group (CNBC TV 19 and CNN TV18). She has also been the Chief Marketing and Revenue Officer at one of India’s leading media groups – NDTV. An environmentalist to the core, she has pioneered and conceptualized India’s best known and award-winning environment campaigns for brands like: Toyota (Greenathon), Aircel (Save Our Tigers), Coca-Cola (Support my...

The equipment and multi-year managed-services contract includes enterprise connectivity, with a large potential for expansion to additional applicationsMulti-Year Strategic Agreement Entered in Asia Pacific for Broadband Connectivity Equipment and Managed ServicesAgreement valued at tens of millions of dollars with potential of significant expansionPETAH TIKVA, Israel, May 03, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that Gilat entered a strategic agreement valued at tens of millions of dollars, including a potential for significant project expansions, with a large government corporation in Asia Pacific. The equipment and multi-year managed-services contract will enable connectivity...

ALPHARETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) for the treatment of macular edema associated with uveitis. Clearside’s resubmission is a full and complete response to all of the items identified in the Complete Response Letter (CRL) received from the FDA on October 18, 2019. Clearside believes this application will be considered a Class 2 resubmission, with a targeted six-month review timeline under the Prescription Drug User Fee Act. “The...

LEXINGTON, Mass. and AMSTERDAM, The Netherlands, May 03, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences:7th Annual Truist Securities Life Sciences Summit, May 4 – 5, 2021Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Tuesday, May 4.American Society of Gene and Cell Therapy (ASGCT) Virtual 2021, May 11 – 14, 2021uniQure will have a significant presence at ASGCT with five data presentations, of which two are oral presentations including:“Clinical Outcomes in Patients With and Without Pre-existing Neutralizing Antibodies to the...

– Acute safety data from the first cohort in the DesCAARTes™ trial announced today; no dose limiting toxicities (DLTs) or clinically relevant adverse events observed in the first dose cohort as of April 30, 2021 – – PLA2R-CAART announced as a new development program for patients with PLA2R-associated membranous nephropathy; pre-IND meeting with FDA planned in the second half of 2021 – – MuSK-CAART Investigational New Drug (IND) application submission planned for the second half of 2021 – PHILADELPHIA, May 03, 2021 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today reported financial results for the first quarter ended March 31, 2021, and provided new pipeline...

New Packaging Solution Addresses the Small Form Factor Requirements for 5G Mobile and WiFi 6E Devices Packages Will Be Manufactured Both In-House and in Outside Supply Chain to Provide Rapid Prototyping and Flexible Capacity Micro Package Compatible Across XBAW Filter Product Line for 5G Mobile, WiFi and Network InfrastructureCharlotte, N.C., May 03, 2021 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it has locked the process flow for its second chip scale package (CSP). The new CSP technology supports the Company’s XBAW® filter products across the 5G mobile, WiFi mobile and CPE and network infrastructure markets. The...